(Press-News.org) A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer. The findings, published November 10 in Cell Reports, reveal how differences among cells within a single tumor influence the cancer’s response to chemotherapy, and introduce a promising new therapy designed to tip the odds in the patients’ favor.
Glioblastoma is notoriously difficult to treat. One of the key reasons is that no two cells within the tumor behave exactly alike. Even inside one tumor, some cells may respond to treatment while others resist it, allowing the cancer to persist and grow. For decades, scientists have known that tumors are composed of diverse cells, but the biological forces driving these differences, and their impact on treatment, have remained elusive.
“Traditionally, researchers have focused on the overall behavior of a tumor by studying the average response across all the individual cells, using differences between the cells to interpret the average,” said senior author Clark Chen, MD, PhD, professor and director of the brain tumor program, department of neurosurgery at Brown University Health. “Our study fundamentally flipped that approach. Rather than focusing on the average response, we focused on the differences between individual cells within the same tumor, and what we found could change how we treat glioblastoma.”
Chen’s team discovered that a small molecule called miR-181d acts like a master switch that helps control how much of a DNA-repair protein called MGMT (short for Methyl-Guanine Methyl Transferase) each glioblastoma cell produces. MGMT is crucial because it allows cancer cells to fix the damage caused by chemotherapy, making them harder to kill. The problem is that not all tumor cells make the same amount of MGMT, some produce a lot, while others make very little. This uneven production means that while some cells die during treatment, others survive to fuel tumor growth.
When glioblastoma tumors are treated with chemotherapy, levels of miR-181d drop. This drop amplifies the differences among individual cells within the tumor, thereby allowing more cells to make more MGMT and survive treatment. The research team found that administering miR-181d into the tumor can reduce this effect, making the cancer cells behave more uniformly, and importantly, more likely to respond to chemotherapy.
“This is an exciting step forward,” commented Gatikrushna Singh, assistant professor of neurosurgery, University of Minnesota and one of the study’s key collaborators. “Scientifically, it helps explain why tumors maintain so much internal variability. Clinically, it opens the door to gene-therapy strategies that could be truly game-changing for many glioblastoma patients.”
The discovery has already led to the development of a new potential therapy aimed at improving patients’ responses to chemotherapy by stabilizing miR-181d levels within the tumor.
This study was a collaborative effort involving scientists from Brown University Health, the University of Minnesota, VisiCELL Medical Inc., Stanford University, and Johns Hopkins University.
###
*Co-authors of this study also include Gatikrushna Singh, Shilpi Singh, Iteeshree Mohapatra, Stefan Kim, Mayur Sharma, University of Minnesota; Johnny Akers, VisiCELL Medical Inc., Thien Nguyen, Stanford University; Efrosini Kokkoli, John Hopkins University; Eric Wong, Margot Martinez Moreno, Shobha Vasudevan, Sean E. Lawler, Wafik S. El-Deiry, Ziya Gokaslan, Brown University Health.
About Brown University Health
Formed in 1994, Brown University Health is a not-for-profit health system based in Providence, R.I. comprised of three teaching hospitals of The Warren Alpert Medical School of Brown University: Rhode Island Hospital and its Hasbro Children’s Hospital; The Miriam Hospital; and Bradley Hospital, the nation’s first psychiatric hospital for children; Newport Hospital, Saint Anne’s Hospital, and Morton Hospital are all community hospitals offering a broad range of health services; Gateway Healthcare, the state’s largest provider of community behavioral health care; Brown Health Medical Group, the largest multi-specialty practice in Rhode Island; and Brown Health Medical Group Primary Care, a primary care driven medical practice. Brown University Health teaching hospitals are among the country’s top recipients of research funding from the National Institutes of Health. The hospitals received over $160 million in external research funding in fiscal 2024. All Brown University Health-affiliated partners are charitable organizations that depend on support from the community to provide programs and services.
END
Researchers are continually looking for new ways to hack the cellular machinery of microbes like yeast and bacteria to make products that are useful for humans and society. In a new proof-of-concept study, a team from the Carl R. Woese Institute for Genomic Biology showed they can expand the biosynthetic capabilities of these microbes by using light to help access new types of chemical transformations.
The paper, published in Nature Catalysis, demonstrates how the bacteria Escherichia coli can be engineered to produce these new molecules in ...
In 2023, more than half of all suicide deaths in the United States involved firearms. “Red flag” laws—also called Extreme Risk Protection Orders or ERPOs—are designed to reduce these deaths by authorizing temporary firearm removal from individuals deemed at high risk of harming themselves or others. ERPO laws had been implemented in 21 states and the District of Columbia as of February 2025.
But the laws’ effectiveness in preventing suicides was still unclear.
However, a new analysis ...
It’s common to wonder as tax season ramps up: Are taxes too high?
According to a new study by University of Cincinnati economics professor David Brasington, the answer is no, at least when it comes to Ohio’s city service taxes. These taxes go toward local services such as funds for the fire department, road repair and park upkeep.
“It seems like public services are not over-provided at the local level in Ohio,” Brasington said. “Because good things seem to happen when people renew these taxes instead of cut them.”
Brasington, PhD, published a new study in Regional Science and Urban Economics called “Effect ...
Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.
Also known as water on the brain, hydrocephalus is caused by a surplus of cerebral spinal fluid (CSF) that increases pressure inside the skull and can damage brain tissue. About 40 per cent of hydrocephalus cases are caused by single gene mutations which impact the brain’s ability to reabsorb CSF ...
Tampa, FL, USA, January 30, 2026: The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented. Sporadic Nipah virus infections have occurred almost annually in parts of South Asia, particularly in India and Bangladesh, and do not indicate a new or escalating global threat.
Nipah ...
Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as “tauopathies”). New research led by Boston Children’s Hospital challenges the current "one-size-fits-all" approach to diagnosing and treating these tauopathies.
The team, led by senior authors Judith A. Steen, PhD, and Hanno Steen, PhD, and executed by co–first authors Mukesh Kumar, PhD, Christoph N. Schlaffner, PhD, Shaojun Tang, PhD, and Maaike A. Beuvink, analyzed brain tissue from 203 patients spanning several tauopathies, including ...
About The Study: This analysis documents a major demographic transition; non-Hispanic white births now constitute less than half of U.S. births, while Hispanic births exceed one-fourth. These shifts reflect declining fertility across most groups, contrasted with immigration trends and younger ages among Hispanic women that sustain overall birth rates.
Corresponding Author: To contact the corresponding author, Amos Grünebaum, MD, email agrunebaum@northwell.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.56659)
Editor’s ...
About The Study: In this cohort study of 47,000 adults participating in the National Health and Nutrition Examination Survey, after accounting for demographic characteristics (e.g., age, race and ethnicity), behavioral factors (e.g., smoking, alcohol use), and chronic conditions (e.g., diabetes, hypertension), males had a 63% greater risk of all-cause mortality than females. These findings suggest that there may be intrinsic biological factors (sex hormones, chromosomes, or immune response) associated with sex differences in mortality. Further research should investigate the effects ...
News Release | Washington University in St. Louis
NEWS RELEASE
Embargoed until 11 a.m. ET Friday, Jan. 30, 2026
MEDIA CONTACT
Abeeha Shamshad · abeeha@wustl.edu · 925-998-0775
Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human cases in the U.S. since 2022, including two fatalities. The virus continues to circulate among ...
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are diagnosed with TB – could save countless lives, the researchers say.
The ATLAS study, conducted over five years at hospitals in Tanzania and Uganda, has found that more than half of the hundreds of patients enrolled in the study had TB and that immediate treatment increased their chances of survival significantly.
The ...
